期刊文献+

院外规范化治疗对急性肺栓塞患者复发的影响 被引量:1

The Influence of Out-of-hospital Standardized Treatment on the Recurrence of Patients with Acute Pulmonary Embolism
下载PDF
导出
摘要 目的急性肺栓塞患者通过院外规范化治疗,研究治疗效果以及影响价值。方法选取该院在2019年1月—2020年1月期间收治的100例急性肺栓塞的患者,以随机数表法作为分组原则,分成50例观察组和50例对照组,其中观察组的治疗方法为院外规范化治疗,对照组采取常规规范化治疗,比较两组患者的复发率、病死率、中断治疗率,比较两组患者的治疗前后的肺灌注缺损评分。结果观察组患者的复发率为8.0%(4/50),病死率为4.0%(2/50),中断治疗率为2.0%(1/50),对照组患者的复发率为24.0%(12/50),病死率为16.0%(8/50),中断治疗率为16.0%(8/50),差异有统计学意义(χ^(2)=4.762、4.000、4.396,P<0.05);观察组和对照组患者的治疗前肺灌注缺损评分比较,差异无统计学意义(P>0.05),观察组治疗4 d、治疗7 d、治疗30 d后的肺灌注缺损评分分别为(13.4±5.1)分、(11.5±5.0)分、(4.7±2.4)分,对照组治疗4 d、治疗7 d、治疗30 d后的患者的肺灌注缺损评分分别为(17.6±7.8)分、(15.6±6.6)分、(9.8±7.0)分,差异有统计学意义(t=3.187、3.501、4.873,P<0.05)。结论通过院外规范化治疗方法对急性肺栓塞患者进行治疗,复发率、病死率大大降低,影响价值较高。 Objective To study the treatment effect and impact value of patients with acute pulmonary embolism through standardized out-of-hospital treatment.Methods Selected 100 patients with acute pulmonary embolism admitted to the hospital from January 2019 to January 2020,used the random number table method as the grouping principle,divided into 50 cases in the observation group and 50 cases in the control group.The treatment method of the observation group was standardized out-of-hospital treatment,and the control group took conventional standardized treatment.The recurrence rate,case fatality rate,and treatment interruption rate of the two groups were compared,and the lung perfusion defect scores of the two groups were compared before and after treatment.Results In the observation group,the recurrence rate was 8.0%(4/50),the case fatality rate was 4.0%(2/50),and the treatment interruption rate was 2.0%(1/50).In the control group,the recurrence rate was 24.0%(12/50),the case fatality rate was 16.0%(8/50),and the treatment interruption rate was 16.0%(8/50),the difference were statistically significant(χ^(2)=4.762,4.000,4.396,P<0.05);comparison of lung perfusion defect scores between observation group and control group before treatment,the difference were not statistically significant(P>0.05),the lung perfusion defect scores of the observation group after 4 days of treatment,7 days of treatment,and 30 days of treatment were(13.4±5.1)points,(11.5±5.0)points,and(4.7±2.4)points,respectively.The lung perfusion defect scores of the patients in the control group after after 4 days of treatment,7 days of treatment and 30 days of treatment were(17.6±7.8)points,(15.6±6.6)points,(9.8±7.0)points,the difference were statistically significant(t=3.187,3.501,4.873,P<0.05).Conclusion The recurrence rate and case fatality rate of patients with acute pulmonary embolism are greatly reduced through standardized out-of-hospital treatment methods,and the impact value is high.
作者 夏洪利 XIA Hongli(Department of Respiratory Medicine,People's Hospital of Hechuan District,Chongqing,401520 China)
出处 《系统医学》 2021年第17期68-70,共3页 Systems Medicine
关键词 院外规范化治疗 急性肺栓塞 复发率 病死率 影响价值 Standardized out-of-hospital treatment Acute pulmonary embolism Recurrence rate Mortality Impact value
  • 相关文献

参考文献11

二级参考文献56

  • 1赵雅宁,郝正玮,李建民,马素慧,沈海涛,陈长香.下肢康复训练机器人对缺血性脑卒中偏瘫患者平衡及步行功能的影响[J].中国康复医学杂志,2012,27(11):1015-1020. 被引量:76
  • 2张馨,林永娟,徐运.缺血性卒中急性期个体化治疗的现状和未来[J].中国医学前沿杂志(电子版),2012,4(4):7-10. 被引量:5
  • 3WRITING GROUP MEMBERS, Lloyd-Jones D, Adams RJ, et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association [J]. Circulation, 2010, 121(7):e46-e215.
  • 4Torbicki A, Perrier A, Konstantinides S, et al. ESC committee for practice guidelines(CPG). Guidelines on the diagnosis and management of acute pulmomary embolism [J]. European Heart Journal, 2008, 29( 18):2276-2315.
  • 5Jaff MR, McMurtry MS, Archer SL, et al. Management of massiveand submassive pulmonary embolism iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary: a scientific statement from the American Heart Association Hypertension [J]. Circulation, 2011, 123(16):1788-830.
  • 6European Society of Cardiology (ESC) Endorsed by the European Respiratory Society (ERS). ESC Guidelines On the diagnosis and management of acute pulmonary embolism [J]. European Heart Journal, 2014(1):1-48.
  • 7Righini M, Kamphuisen PW, Le Gal G. Age-adjusted D-dimer cutoff levels and pulmonary embolism--reply[J]. JAMA, 2014, 312(5):557-558.
  • 8Wang C, Zhai Z, Yang YH, et al. Efficacy and safety of lower dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary embolism [J]. Chest, 2010(137):254-262.
  • 9Guyatt GH, Norris SL, Schulman S, et al. Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotie Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest, 2012, 141(2 Suppl):53S-70S.
  • 10Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for vte disease: chest guideline and expert panel report [J]. Chest, 2016, 149(2):315-352.

共引文献47

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部